10.1002/cam4.1670 115 ZhuD.OsukaS.ZhangZ.ReichertZ
Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases
To detect growth in the presence of drugs or growth inhibitors, the following susceptibility test disks from Thermo Scientific were used: Oxoid An-Ident discsincluding Erythromycin, 60 g, Rifampin, 15 g, Colistin, 10 g, Penicillin, 2 units, Kanamycin, 1000 g and Vancomycin, 5 g (R65006), Oxoid Amoxycillin Antimicrobial Susceptibility discs (11953032), Oxoid Amoxycillin/Clavulanic Acid Antimicrobial Susceptibility discs (11913812), Oxoid Azithromycin Antimicrobial Susceptibility discs (10660125), Oxoid Cefoxitin Antimicrobial Susceptibility discs (11944022), Oxoid Ciprofloxacin Antimicrobial Susceptibility discs (10351253), Oxoid Clindamycin Antimicrobial Susceptibility discs (11994012), Oxoid Doxycycline Antimicrobial Susceptibility discs (11943022), Oxoid Metronidazole Antimicrobial Susceptibility discs (11913972), Oxoid Minocycline Antimicrobial Susceptibility discs (11924002), Oxoid Moxifloxacin Antimicrobial Susceptibility discs (10431893), Oxoid Ofloxacin Antimicrobial Susceptibility discs (11912952), Oxoid Penicillin G Antimicrobial Susceptibility discs (12761760), Oxoid Spiramycin Antimicrobial Susceptibility Disks, 100 g (10451323) and Oxoid Tetracycline Antimicrobial Susceptibility discs (11963872)
Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction
doi: 10.1007/s00424-020-02439-5 44
Breakthrough compound for mitochondrial function studies
